Related Experiment Video
Updated: May 21, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Diphtheria-tetanus-pertussis vaccination administered after measles vaccine: increased female mortality?
Christine Stabell Benn1, Peter Aaby
1Bandim Health Project, Research Center for Vitamins and Vaccines, Statens Serum Institut, Copenhagen S, Denmark. cb@ssi.dk
Insights
Delayed diphtheria-tetanus-pertussis (DTP) vaccination after measles vaccine increases mortality risk in female children in low-income countries. This sex-differential effect highlights the importance of timely DTP immunization for young girls.
Area of Science:
- Pediatrics
- Immunology
- Global Health
Background:
- Standard childhood immunization schedules in low-income countries recommend diphtheria-tetanus-pertussis (DTP) vaccine at 6, 10, and 14 weeks and measles vaccine at 9 months.
- Deviations from the schedule are common, with DTP often administered after the measles vaccine.
- Prior studies suggest this delayed DTP vaccination may disproportionately increase mortality risk in female infants.
Purpose of the Study:
- To investigate the association between delayed diphtheria-tetanus-pertussis (DTP) vaccination and sex-differential mortality.
- To determine if missing DTP doses at 9 months impacts mortality risk differently in male and female children.
Main Methods:
- Analysis of vaccination data from 455 children participating in a vitamin A trial in Guinea-Bissau.
- Vaccination status for DTP was recorded at the time of measles vaccination (9 months of age).
- Mortality risk was compared between children missing DTP doses and those who received all DTP doses by 36 months of age, stratified by sex.
Main Results:
- Of 455 children, 141 (31%) were missing at least one DTP dose at 9 months.
- Female children missing DTP vaccination showed a 3.55 times higher risk of mortality before 36 months (95% CI: 1.23-10.26).
- No significant difference in mortality risk was observed for male children missing DTP vaccination (0.97 [0.34-2.80]).
Conclusions:
- The findings support a negative impact of receiving diphtheria-tetanus-pertussis (DTP) vaccine after measles vaccine on female children's survival.
- Timely administration of the DTP vaccine series is crucial, particularly for female infants, to mitigate potential mortality risks.
- This sex-specific association warrants further investigation into the biological or social mechanisms underlying the observed disparities.
Abstract:
In low-income countries, children should receive 3 doses of diphtheria-tetanus-pertussis vaccine (DTP) at 6, 10 and 14 weeks of age, and measles vaccine at 9 months of age. However, there is often a delay in administering the vaccines, and DTP is often given after measles vaccine. Previous observations suggest that this practice is associated with increased mortality for female, but not for male children. Within a vitamin A trial in Guinea-Bissau, vaccination status was registered at the time of measles vaccination at 9 months; 141 (31%) of 455 children were missing 1 or more DTP vaccines and were likely to receive them afterward. We examined whether missing DTP vaccine at this time point was associated with sex-differential effects on mortality. In female children, missing DTP was associated with 3.55 (95% confidence interval: 1.23-10.26) times higher risk of dying before 36 months of age, whereas it made no difference in male children (0.97 [0.34-2.80]). The result supports that receiving DTP after measles vaccine affects female children negatively.
Related Concept Videos
Diphtheria
Vaccinations
Teratogenicity
Probability Laws
Toxicity Testing in Animals
Bacterial Meningitis I: Introduction
